LNP-SORT

Welcome to the Brand page for “LNP-SORT”, which is offered here for Providing information, providing online, non-downloadable articles, books, magazines, journals, and scientific texts in the fields of genetic medicine and drug delivery;medicines for the modification of genes and treatment of diseases, for use in the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; cell and gene therapy preparations and pharmaceutical preparations with protein expression, all for the treatment of respiratory diseases, lung diseases, central nervous system diseases, immunodeficiency and autoimmune diseases, infectious diseases, liver diseases, metabolic disorders, muscular diseases, and cancer; drug carriers for medical use, delivery agents in the form of non-viral lipid nanoparticles for delivering drugs to human organs;lipid nanoparticle selective organ targeting;providing medical information in the fields of genetic medicine and drug delivery;scientific and biotechnology research and analysis in the fields of cell and gene therapy and drug delivery; research and development of medicines and drug delivery platforms for the treatment of diseases; providing scientific research and medical research information in the fields of genetic medicine and drug delivery;.

Its status is currently believed to be active. Its class is unavailable. “LNP-SORT” is believed to be currently owned by “ReCode Therapeutics, Inc.”